Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
Authors:
- H J DuffHDH J Duff
- D RodenDRD Roden
- R K PrimmRPR K Primm
- J A OatesJOJ A Oates
- R L WoosleyRWR L Woosley
- 1 May 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 67 (5) , 1124-1128
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTIONThe Lancet, 1980
- Mexiletine therapy in 15 patients with drug-resistant ventricular tachycardiaThe American Journal of Cardiology, 1980
- MexiletineDrugs, 1979
- Long-term oral antiarrhythmic therapy with mexiletine.Heart, 1978
- Management of patients with malignant ventricular arrhythmiasThe American Journal of Cardiology, 1977
- Long-term treatment of ventricular arrhythmias with oral mexiletineAmerican Heart Journal, 1976
- Drug interactions in cardiovascular therapyAmerican Heart Journal, 1975
- COMPARISON OF PROCAINAMIDE AND MEXILETINE IN PREVENTION OF VENTRICULAR ARRHYTHMIAS AFTER ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1975
- MEXILETINE (K 1173) IN THE MANAGEMENT OF VENTRICULAR DYSRHYTHMIASThe Lancet, 1973
- Antiarrhythmic Drugs: Electrophysiological ActionsAnnual Review of Pharmacology, 1971